Moberg Pharma: Outcome of Rights issue – oversubscribed - Redeye

Redeye briefly comments on the news about the outcome of the rights issue. The subscription rate was 130%; thus, the rights issue was fully subscribed, and no issue guarantors were used. Moberg Pharma will receive SEK 100m before transaction costs.

Länk till analysen i sin helhet: https://www.redeye.se/research/941393/moberg-pharma-outcome-of-rights-issue-oversubscribed?utm_source=finwire&utm_medium=RSS